Chimeric Antigen Receptor (CAR)-T cell therapy and other cell therapies have made great advancements in fighting cancer in recent years, but several challenges remain, including evaluating product quality, predicting patient response and risk of adverse effects, and overcoming immunosuppressive microenvironments in solid tumors. However, recent advancements may help to improve cell therapy efficacy.
In this eBook, we will cover recent cutting-edge research in cellular therapy, as well as several cases in which functional proteomics technology was used to optimize cell therapies at every stage of the development pipeline, filling critical gaps in cell therapy product quality assessment and predictive biomarker discovery.
Sponsored by:
